You have 9 free searches left this month | for more free features.

AN05

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depression, Bipolar Trial in Aalborg (Lithium, Cariprazine)

Recruiting
  • Depression, Bipolar
  • Aalborg, Denmark
    Aalborg University Hospital
Jun 19, 2023

Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pigmented Villonodular Synovitis
  • AMB-05X
  • Columbus, Ohio
  • +5 more
Oct 5, 2022

Schizophrenia and Related Disorders, MDD, Bipolar Depression Trial (Clozapine, Esketamine Nasal Product, Escitalopram)

Not yet recruiting
  • Schizophrenia and Related Disorders
  • +2 more
  • (no location specified)
Jan 12, 2023

Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

Active, not recruiting
  • Uveitis
  • +2 more
  • Sham Injector
  • FAI Insert
  • Waltham, Massachusetts
    EyePoint Study Site
Dec 20, 2022

Hepatic Impairment Trial in Kistarcsa, Bratislava (Fazirsiran)

Not yet recruiting
  • Hepatic Impairment
  • Kistarcsa, Hungary
  • +1 more
May 26, 2023

Hepatic Impairment, Healthy Subjects Trial in Kiel, Jozefow (Aprocitentan)

Completed
  • Hepatic Impairment
  • Healthy Subjects
  • Kiel, Germany
  • +1 more
Nov 22, 2022

Breast Cancer, Psychological Distress Trial in Los Angeles (Improvisational comedy classes, Waitlist control)

Active, not recruiting
  • Breast Cancer
  • Psychological Distress
  • Improvisational comedy classes
  • Waitlist control
  • Los Angeles, California
    Cedars Sinai Medical Center
Sep 19, 2022

The Benefit ofDeep Cleansing Gel in Management of Mild to

Completed
  • Acne
  • Deep Cleansing Gel
  • Rio de Janeiro, Brazil
    CIDP
Oct 14, 2022

Atopic Dermatitis Trial in Nice (tested formula with fiber, Control)

Recruiting
  • Atopic Dermatitis
  • tested formula with fiber
  • Control
  • Nice, France
    Center_05
Jul 18, 2022

Plaque Psoriasis Trial in Canada, United States (Vectical™ Ointment weekdays and Clobex® Spray weekends regimen, Clobex® Spray

Completed
  • Plaque Psoriasis
  • Vectical™ Ointment weekdays and Clobex® Spray weekends regimen
  • Clobex® Spray morning and Vectical™ Ointment evening regimen
  • Los Angeles, California
  • +5 more
Jul 28, 2022

Plaque Psoriasis Trial in Fountain Valley, Hialeah, Saint Joseph (Halobetasol Topical Lotion)

Terminated
  • Plaque Psoriasis
  • Halobetasol Topical Lotion
  • Fountain Valley, California
  • +2 more
Dec 6, 2021

Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral

Recruiting
  • Pulmonary Vascular Disorder
  • +3 more
  • Riociguat Oral Tablet
  • Placebo
  • Dresden, Germany
  • +1 more
Jan 26, 2023

Melasma Trial in Los Angeles, Dallas (Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%)

Completed
  • Melasma
  • Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
  • Los Angeles, California
  • +1 more
Jul 28, 2022

Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

Not yet recruiting
  • Breast Cancer
  • +2 more
  • LS301-IT 0.025 mg/kg
  • +3 more
  • Scottsdale, Arizona
    Integro Theranostics Research Site #1
Jun 2, 2023

MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)

Enrolling by invitation
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • New York, New York
    Axsome Research Site
Jul 20, 2021

Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and

Completed
  • Contraception
  • Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
  • +2 more
  • (no location specified)
Feb 2, 2022

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Treatment Resistant Depression, MDD Trial in United States (AXS-05 (dextromethorphan-bupropion))

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • AXS-05 (dextromethorphan-bupropion)
  • Little Rock, Arkansas
  • +19 more
Jun 2, 2022

Bipolar Depression Trial in Worldwide (Escitalopram, Sertraline, Duloxetine)

Not yet recruiting
  • Bipolar Depression
  • Innsbruck, Austria
  • +12 more
Jul 25, 2023

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation, Psychomotor Trial in United States (AXS-05

Enrolling by invitation
  • Agitation in Patients With Dementia of the Alzheimer's Type
  • +2 more
  • AXS-05 (dextromethorphan-bupropion)
  • Lafayette, California
  • +26 more
Sep 29, 2022

Aflibercept in Routine Clinical Practice in Diabetic Macular

Completed
  • Macular Edema
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
  • Multiple Locations, United Kingdom
    (unnamed)
Nov 1, 2021

Hypertension, Pulmonary Trial in Worldwide (Adempas (Riociguat, BAY63-2521))

Recruiting
  • Hypertension, Pulmonary
  • Adempas (Riociguat, BAY63-2521)
  • Besancon, France
  • +15 more
Jan 31, 2023

Type1 Diabetes Trial (BOL-DP-o-05, Placebo)

Withdrawn
  • Type1 Diabetes Mellitus
  • (no location specified)
Mar 22, 2021

Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Heidelberg (Riociguat)

Recruiting
  • Primary Pulmonary Arterial Hypertension
  • Chronic Thromboembolic Pulmonary Hypertension
  • Heidelberg, Germany
    Centre for Pulmonary Hypertension at the Thoraxklinik Heidelberg
Apr 14, 2022

Allergic Rhinitis Trial in Anshan (Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).)

Not yet recruiting
  • Allergic Rhinitis
  • Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).
  • Anshan, Guizhou, China
    Guangjun Tang
Oct 5, 2022